Publications by authors named "Marc Webster"

Claim this Profile
Z
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study.
Santiago Escrivá-de-Romani, Juan M Cejalvo, Emilio Alba, Jennifer Friedmann, Álvaro Rodríguez-Lescure, Marc Webster

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician's guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer.
Marya Hussain, Christine Brezden-Masley, Stephen Chia, Giuseppe Curigliano, Marc Webster

Ther Adv Med Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting.
Mita Manna, Karen A Gelmon, Jean-François Boileau, Christine Brezden-Masley, Jeffrey Q Cao, Marc Webster

Curr Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trial.
Margaret L McNeely, Naomi D Dolgoy, Bolette Skjodt Rafn, Sunita Ghosh, Paula A Ospina, Marc Webster

Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.
Elizabeth N Kornaga, Alexander C Klimowicz, Natalia Guggisberg, Travis Ogilvie, Don G Morris, Marc Webster

Mod Pathol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Neuroendocrine Carcinoma Following High-Dose Radiotherapy for Head and Neck Cancer: Report of Two Cases.
Amandeep S Taggar, Roderick Simpson, Desiree Hao, Marc Webster, Moosa Khalil

Cureus· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort.
Elizabeth N Kornaga, Alexander C Klimowicz, Natalia Guggisberg, Travis Ogilvie, Don G Morris, Marc Webster

Mod Pathol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of night-time compression for breast cancer related lymphedema (LYNC): protocol for a multi-centre, randomized controlled efficacy trial.
Margaret L McNeely, Kristin L Campbell, Marc Webster, Urve Kuusk, Karen Tracey

BMC Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.
John R Mackey, Manuel Ramos-Vazquez, Oleg Lipatov, Nicole McCarthy, Dmitriy Krasnozhon, Marc Webster

J Clin Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
Haley Augustine, Monique Munro, Feisal Adatia, Marc Webster, Michael Fielden

Can J Ophthalmol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A teaching model for aromatase inhibitors after tamoxifen.
Theresa Trotter, Marc Webster, Cindy Railton, A H G Paterson, Tyrone Donnon

J Cancer Educ· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of SarCNU in malignant glioma: unexpected pulmonary toxicity with a novel nitrosourea: a phase II trial of the national cancer institute of canada clinical trials group.
Marc Webster, Gregory Cairncross, Stan Gertler, James Perry, Nancy Wainman

Invest New Drugs· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII?
Philip S Wells, Nicole J Langlois, Marc A Webster, James Jaffey, Josdalyne A Anderson

Thromb Haemost· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis